You just read:

Synthetic Biologics Strengthens U.S. Patent Coverage of SYN-010, Intended for the Novel Treatment of Irritable Bowel Syndrome with Constipation (IBS-C)

News provided by

Synthetic Biologics, Inc.

Sep 26, 2019, 07:00 ET